United States - English - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - penicillin v potassium (unii: 146t0tu1jb) (penicillin v - unii:z61i075u2w) - penicillin v potassium tablets, usp and penicillin v potassium for oral solution, usp, are indicated in the treatment of mild to moderately severe infections due to penicillin g- sensitive microorganisms. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. note: severe pneumonia, empyema, bacteremia, pericarditis, meningitis, and arthritis should not be treated with penicillin v during the acute stage. indicated surgical procedures should be performed. the following infections will usually respond to adequate dosage of penicillin v: streptococcal infections (without bacteremia): mild-to-moderate infections of the upper respiratory tract, scarlet fever and mild erysipelas. note: streptococci in groups a, c, g, h, l, and m are very sensitive to penicillin. other groups, including group d (enterococcus) are resistant. pneumococcal infections : mild to moderately severe infections of the respiratory tract. staphylococcal infections - penicillin g sensi

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - phenoxymethylpenicillin benzathine -

New Zealand - English - Medsafe (Medicines Safety Authority)

multichem nz limited - phenoxymethylpenicillin potassium 277.18mg equivalent to phenoxymethylpenicillin 250 mg - film coated tablet - 250 mg - active: phenoxymethylpenicillin potassium 277.18mg equivalent to phenoxymethylpenicillin 250 mg excipient: basic butylated methacrylate copolymer calcium hydrogen phosphate dihydrate macrogol 6000 magnesium stearate maize starch microcrystalline cellulose purified water sodium laurilsulfate stearic acid titanium dioxide - phenoxymethylpenicillin is indicated in the treatment of mild to moderately severe infections due to penicillin sensitive organisms. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. for prophylactic use in recurrent streptococcal infections including the prevention of recurrence following rheumatic fever and/or sydenham's chorea and to prevent bacterial endocarditis in patients with rheumatic fever and/or congenital heart disease who are about to undergo dental or upper respiratory surgery or instrumentation.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - phenoxymethylpenicillin benzathine, quantity: 40.27 mg/ml (equivalent: phenoxymethylpenicillin, qty 30 mg/ml) - oral liquid, suspension - excipient ingredients: sodium propyl hydroxybenzoate; sodium methyl hydroxybenzoate; butylated hydroxyanisole; polysorbate 80; xanthan gum; sucrose; purified water; sodium citrate dihydrate; potassium sorbate; citric acid; flavour - treatment of mild to moderately severe infections due to penicillin sensitive staphylococci, pneumococci, gonococci and haemolytic streptococci infections. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. for prophylactic use in recurrent streptococcal infections including the prevention of recurrence following rheumatic fever and/or sydenham's chorea and to prevent bacterial endocarditis in patients with rheumatic fever and/or congenital heart disease who are about to undergo dental or upper respiratory surgery or instrumentation. note: oral penicillin should not be used as adjunctive prophylaxis for genitourinary instrumentation or surgery, lower intestinal tract surgery, sigmoidoscopy or complications of childbirth.

United States - English - NLM (National Library of Medicine)

liberty pharmaceuticals, inc. - penicillin v potassium (unii: 146t0tu1jb) (penicillin v - unii:z61i075u2w) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of penicillin v potassium tablets, penicillin v potassium for oral solution and other antibacterial drugs, penicillin v potassium tablets, and penicillin v potassium for oral solution should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antimicrobial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. penicillin v potassium tablets, usp and penicillin v potassium for oral solution, usp, are indicated in the treatment of mild to moderately severe infections due to penicillin g sensitive microorganisms. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. note: severe pneumonia, empyema, bacteremia, pericardit

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - phenoxymethylpenicillin potassium 28.284 mg/ml equivalent to 25 mg/ml phenoxymethylpenicillin.;  ;   - granules for oral solution - 125 mg/5ml - active: phenoxymethylpenicillin potassium 28.284 mg/ml equivalent to 25 mg/ml phenoxymethylpenicillin.     excipient: orange 175-78-8 orange flavour j1978 10814413 saccharin sodium sodium benzoate sucrose as caster sugar. - treatment of mild to moderately severe infections caused by penicillin-sensitive organisms. the following infections will usually respond to an adequate dosage of penicillin.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - phenoxymethylpenicillin potassium 56.568 mg/ml equivalent to 50 mg/ml phenoxymethylpenicillin;  ;   - granules for oral solution - 250 mg/5ml - active: phenoxymethylpenicillin potassium 56.568 mg/ml equivalent to 50 mg/ml phenoxymethylpenicillin     excipient: orange 175-78-8 orange flavour j1978 10814413 saccharin sodium sodium benzoate sucrose as caster sugar. - treatment of mild to moderately severe infections caused by penicillin-sensitive organisms. the following infections will usually respond to an adequate dosage of penicillin.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - phenoxymethylpenicillin potassium - oral tablet - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - phenoxymethylpenicillin potassium - oral tablet - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - phenoxymethylpenicillin potassium - oral tablet - 250mg